Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

ENDRA Life Sciences Inc. Common Stock (NDRA)

Electromedical & Electrotherapeutic Apparatus

https://www.endrainc.com

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

3600 GREEN COURT, SUITE 350
ANN ARBOR, MI

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/28/2017

Market Cap

2,944,451

Shares Outstanding

8,460,000

Weighted SO

8,454,922

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

BNR --.--%

STIM --.--%

DRIO --.--%

GTH --.--%

SERA --.--%

STRRP --.--%

LAB --.--%

BDSX --.--%

Beta

0.8170

Last Div

0.0000

Range

0.0382-2.79

Chg

-0.0101

Avg Vol

23248988

Mkt Cap

2944451

Exch

NASDAQ

Country

US

Phone

734 335 0468

DCF Diff

-0.2534

DCF

0.3833

Div Yield

0.0000

P/S

6.8730

EV Multiple

0.3270

P/FV

0.1271

Div Yield %

0.0000

P/E

-0.1195

PEG

-0.0018

Payout

-0.0006

Current Ratio

4.9723

Quick Ratio

2.9637

Cash Ratio

4.7407

DSO

0.0000

DIO

5282.8165

Op Cycle

5282.8165

DPO

0.0000

CCC

5282.8165

Gross Margin

0.5626

Op Margin

-22.4005

Pretax Margin

-22.3274

Net Margin

-22.3274

Eff Tax Rate

-0.0115

ROA

-0.9160

ROE

-1.6248

ROCE

-1.0555

NI/EBT

1.0000

EBT/EBIT

0.9967

EBIT/Rev

-22.4005

Debt Ratio

0.0363

D/E

0.0422

LT Debt/Cap

0.0214

Total Debt/Cap

0.0405

Int Coverage

2807.6463

CF/Debt

-24.2014

Equity Multi

1.1611

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0691

FA Turnover

1.1767

Asset Turnover

0.0410

OCF/Share

-0.3367

FCF/Share

-0.3379

Cash/Share

0.2346

OCF/Sales

-21.4427

FCF/OCF

1.0037

CF Coverage

-24.2014

ST Coverage

-50.2714

CapEx Coverage

-271.1085

Div&CapEx Cov

-231.6482

P/BV

0.1271

P/B

0.1271

P/S

6.8730

P/E

-0.1195

P/FCF

-0.3194

P/OCF

-0.1244

P/CF

-0.1244

PEG

-0.0018

P/S

6.8730

EV Multiple

0.3270

P/FV

0.1271

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation